Enhancing the Antiviral Potency of Nucleobases for Potential Broad-Spectrum Antiviral Therapies

Broad-spectrum antiviral therapies hold promise as a first-line defense against emerging viruses by blunting illness severity and spread until vaccines and virus-specific antivirals are developed. The nucleobase favipiravir, often discussed as a broad-spectrum inhibitor, was not effective in recent...

Descripción completa

Detalles Bibliográficos
Autores principales: Soto-Acosta, Ruben, Edwards, Tiffany C., Dreis, Christine D., Krishna, Venkatramana D., Cheeran, Maxim C-J., Qiu, Li, Xie, Jiashu, Bonnac, Laurent F., Geraghty, Robert J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705664/
https://www.ncbi.nlm.nih.gov/pubmed/34960780
http://dx.doi.org/10.3390/v13122508

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705664/
https://www.ncbi.nlm.nih.gov/pubmed/34960780
http://dx.doi.org/10.3390/v13122508

Ejemplares similares